BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PRRX1, ENSG00000116132, 5396 AND Treatment
6 results:

  • 1. Heterogeneity and transcriptional drivers of triple-negative breast cancer.
    Jovanović B; Temko D; Stevens LE; Seehawer M; Fassl A; Murphy K; Anand J; Garza K; Gulvady A; Qiu X; Harper NW; Daniels VW; Xiao-Yun H; Ge JY; Alečković M; Pyrdol J; Hinohara K; Egri SB; Papanastasiou M; Vadhi R; Font-Tello A; Witwicki R; Peluffo G; Trinh A; Shu S; Diciaccio B; Ekram MB; Subedee A; Herbert ZT; Wucherpfennig KW; Letai AG; Jaffe JD; Sicinski P; Brown M; Dillon D; Long HW; Michor F; Polyak K
    Cell Rep; 2023 Dec; 42(12):113564. PubMed ID: 38100350
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing prrx1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Association of Overall Annual Hospital Volume and Perioperative Outcomes following Free Flap breast Reconstruction.
    Shammas RL; Ren Y; Thomas SM; Phillips BT; Hollenbeck ST; Greenup RA
    Plast Reconstr Surg; 2021 Feb; 147(2):196e-206e. PubMed ID: 33565821
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Paired‑related homeobox 1 overexpression promotes multidrug resistance via PTEN/PI3K/AKT signaling in MCF‑7 breast cancer cells.
    Luo H; Cong S; Dong J; Jin L; Jiang D; Wang X; Chen Q; Li F
    Mol Med Rep; 2020 Oct; 22(4):3183-3190. PubMed ID: 32945446
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Failure of sentinel lymph node mapping in breast cancer patients qualified for treatment sparing axillary lymph nodes-Clinical importance and management strategy-One-center analysis.
    Nowikiewicz T; Głowacka-Mrotek I; Tarkowska M; Nowikiewicz M; Zegarski W
    Breast J; 2020 May; 26(5):873-881. PubMed ID: 31999025
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Optimal Surgical Management for Occult breast Carcinoma: A Meta-analysis.
    Macedo FI; Eid JJ; Flynn J; Jacobs MJ; Mittal VK
    Ann Surg Oncol; 2016 Jun; 23(6):1838-44. PubMed ID: 26832884
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.